Healthcare & Life Sciences
Keros Therapeutics
United Stateswww.kerostx.com
Keros Therapeutics is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2
Investors
About Keros Therapeutics
Keros Therapeutics is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Keros Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops therapies that modulate transforming growth factor‑beta (TGF‑β) family signaling to treat hematological, musculoskeletal, pulmonary, and cardiovascular disorders.
Explore Keros Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.